Head-To-Head Review: IRIS International (IRIS) and Lantheus (LNTH)

Lantheus (NASDAQ: LNTH) and IRIS International (NASDAQ:IRIS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Institutional and Insider Ownership

92.0% of Lantheus shares are held by institutional investors. Comparatively, 68.9% of IRIS International shares are held by institutional investors. 2.3% of Lantheus shares are held by company insiders. Comparatively, 9.7% of IRIS International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

Lantheus has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, IRIS International has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500.

Profitability

This table compares Lantheus and IRIS International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Lantheus 9.59% -46.45% 16.42%
IRIS International -61.58% -36.70% -29.47%

Valuation & Earnings

This table compares Lantheus and IRIS International’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Lantheus $301.85 million 2.54 $26.76 million $0.81 25.19
IRIS International N/A N/A N/A $0.04 201.25

Lantheus has higher revenue and earnings than IRIS International. Lantheus is trading at a lower price-to-earnings ratio than IRIS International, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings for Lantheus and IRIS International, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lantheus 0 1 3 0 2.75
IRIS International 0 0 0 0 N/A

Lantheus currently has a consensus target price of $24.00, suggesting a potential upside of 17.65%. Given Lantheus’ higher possible upside, equities research analysts clearly believe Lantheus is more favorable than IRIS International.

Summary

Lantheus beats IRIS International on 7 of the 10 factors compared between the two stocks.

Lantheus Company Profile

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

IRIS International Company Profile

Mitcham Industries, Inc. is a provider of equipment to the geophysical, oceanographic and hydrographic industries. The Company operates through two segments. The Equipment Leasing segment is primarily engaged in the leasing of seismic equipment to companies in the oil and gas industry across the world. The Equipment Manufacturing and Sales segment is engaged in the design, production and sale of marine seismic equipment, and oceanographic and hydrographic equipment. Its leasing business includes Mitcham Canada ULC, Seismic Asia Pacific Pty Ltd., Mitcham Seismic Eurasia LLC, Mitcham Europe Ltd. and Mitcham Marine Leasing Pte. Ltd. The Equipment Manufacturing and Sales Segment includes its Seamap International Holdings Pte, Ltd. (Seamap) business and Klein Marine Systems, Inc. (Klein). Seamap designs, manufactures and sells a range of products for the seismic, hydrographic and offshore industries. Klein develops and manufactures high performance side scan sonar systems.

Receive News & Ratings for Lantheus Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply